Connected Drug Injection Devices to 2020
What Therapeutic Areas Are the Current Focus of Connected Devices?
/EINPresswire.com/ -- DUBLIN, IRELAND--(Marketwired - March 16, 2016) - Research and Markets has announced the addition of the "Connected Drug Injection Devices" report to their offering.
For self-administration, adherence with drug therapy and disease management protocols has become a primary concern within the healthcare and pharmaceutical industries. For chronic conditions adherence has a direct effect on the patient's quality-of-life.
Efforts to enhance adherence have a non-negligible effect on drug formulations and delivery decisions, and are a significant factor in the prescribing decisions of most physicians. The connected device ecosystem includes OEM device suppliers, drug developers, human factors consultants and aftermarket third-party devices.
What You Will Learn:
- What drug injection devices incorporate wireless connectivity technology, how do they work and what new capabilities do they offer to patients and their HCPs?
- What benefits do connected drug injectors provide to patients in the area of improved adherence? Patient reported outcomes? HCP/patient communication?
- What therapeutic areas are the current focus of connected devices?
- Who are the companies behind the push to connected injection devices? What are their development activities and corporate alliances and affiliations
- What is the importance of pharma-device alliances and design partnerships on connected drug injection device commercialization and market access?
- What does the current market for connected drug injection devices look like? What will it look like in 2020?
- What are the key market drivers for the growth of connected injection devices?
Who Should Read This Report:
Development:
- Drug Developers
- Device Suppliers
- CMOs
- Components/APIs
- Testing/Validation
- Clinical Trial Mgmt
Industry:
- Pharma Managers
- Biotech Managers
- Drug Marketers
- Industry Strategists
- Financial Analysts
- Management
- Consultants
Market:
- Clinical Managers
- Drug Distributors
- Pharma Regulators
- FDA Consultants
- Managed Care Managers
Key Topics Covered:
1. Executive Summary
2. Connected Devices -- The Opportunity
- Injectable Drug Development Trends
- The Rapid Rise of Prefilled Injection Devices
- Factors Driving Drug Self-Administration
- Therapeutic Demand Drivers
- The Impact of Developing Economies
3. Connectivity Technologies
- Wireless Technologies
- Bluetooth
- Cellular
- Near Field Communications
- Wired Technologies
4. Connected Devices
5. Wearable Devices
- Connected Autoinjectors
- Non-drug Specific Connected Injectors
- Self-powered Devices
- Automated Connected Injectors
- Vendor-specific Connectivity Platforms
6. Third Party Connectivity Devices
7. Near-term Markets for Connected Injection Devices
- Anaphylaxis
- Autoimmune Disease
- Cardiovascular
- Diabetes
- Hormone Replacement
8. Market Factors
- Regulatory Requirements
- Data Security
- Patient Acceptance
9. Company Profiles
For more information visit http://www.researchandmarkets.com/research/6rzbpq/connected_drug
Sector: Infusions and Injectables, Needles and Syringes
Image Available: http://www.marketwire.com/library/MwGo/2016/3/16/11G087780/Images/connected_drug_injection_devices-08226c6cf608ae67a6d33f10b4c76c0c.jpg
Research and Markets
Laura Wood
Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Connected Drug Injection Devices Report Sample
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
